AlphaStar Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AlphaStar Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263K	Sell	2,058 -13	-0.6%	-$1.62K	0.02%	206
2025 Q4	$253K	Sell	2,071 -239	-10%	-$27.4K	0.02%	218
2025 Q3	$231K	Sell	2,310 -530	-19%	-$47.7K	0.02%	179
2025 Q2	$235K	Sell	2,840 -87	-3%	-$6.94K	0.02%	327
2025 Q1	$237K	Sell	2,927 -54	-2%	-$4.83K	0.02%	166
2024 Q4	$268K	Sell	2,981 -206	-6%	-$20K	0.03%	173
2024 Q3	$315K	Buy	+3,187	New	+$313K	0.03%	302
2021 Q1	–	Sell	-9,258	Closed	-$1.41M	–	243
2020 Q4	$1.41M	Sell	9,258 -1,798	-16%	-$230K	0.24%	82
2020 Q3	$1.31M	Buy	+11,056	New	+$1.24M	0.26%	81

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AlphaStar Capital Management's XBI Position: Q1 2026 in Review

AlphaStar Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.63% in Q1 2026, selling an estimated $1.62K and leaving 2,058 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #206.

AlphaStar Capital Management first reported a position in XBI in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.41M in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

AlphaStar Capital Management held 2,058 shares of State Street SPDR S&P Biotech ETF worth $263K as of Q1 2026.
AlphaStar Capital Management sold 13 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.62K.
State Street SPDR S&P Biotech ETF made up 0.02% of AlphaStar Capital Management's portfolio in Q1 2026, its #206 holding.
AlphaStar Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 9 quarters since.
AlphaStar Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.41M in Q4 2020.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on AlphaStar Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.